Literature DB >> 25312407

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis.

Stanislas Faguer1,2,3, François Vergez2,4, Michael Peres2, Inès Ferrandiz1, Audrey Casemayou3, Julie Belliere1,2,3, Olivier Cointault1, Laurence Lavayssiere1, Marie-Béatrice Nogier1, Grégoire Prevot5, Antoine Huart1, Christian Recher2,6, Lionel Rostaing1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25312407     DOI： 10.1002/hon.2174

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  7 in total

Review 1.  Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).

Authors:  Xianyao Wang; Zhixu He; Xing Zhao
Journal:  Exp Ther Med       Date:  2021-02-03       Impact factor: 2.447

2.  Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.

Authors:  Sabrin Albeituni; Katherine C Verbist; Paige E Tedrick; Heather Tillman; Jennifer Picarsic; Rachel Bassett; Kim E Nichols
Journal:  Blood       Date:  2019-04-23       Impact factor: 22.113

3.  Successful Treatment of immune Reconstitution Inflammatory syndrome-related Hemophagocytic Syndrome in an HIV Patient with Primary Effusion Lymphoma.

Authors:  Markela-P Zorzou; Maria Chini; Athina Lioni; Georgios Tsekes; Thomas Nitsotolis; Ioannis Tierris; Nicolaos Panagiotou; Dimitra Rontogianni; Nicolaos Harhalakis; Marios Lazanas
Journal:  Hematol Rep       Date:  2016-12-22

4.  IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome.

Authors:  Etienne Dufranc; Arnaud Del Bello; Julie Belliere; Nassim Kamar; Stanislas Faguer
Journal:  Crit Care       Date:  2020-04-22       Impact factor: 9.097

5.  Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.

Authors:  Stanislas Faguer; Arnaud Del Bello; Florence Abravanel; Marie-Laure Nicolau-Travers; Nassim Kamar
Journal:  Ann Intern Med       Date:  2020-05-18       Impact factor: 25.391

6.  Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study.

Authors:  Ju Yeon Kim; Miso Kim; Jin Kyun Park; Eun Bong Lee; Jun Won Park; Junshik Hong
Journal:  Orphanet J Rare Dis       Date:  2022-09-21       Impact factor: 4.303

7.  Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Authors:  Matthew J Frigault; Sarah Nikiforow; Michael K Mansour; Zhen-Huan Hu; Mary M Horowitz; Marcie L Riches; Peiman Hematti; Cameron J Turtle; Mei-Jie Zhang; Miguel-Angel Perales; Marcelo C Pasquini
Journal:  Blood       Date:  2020-07-02       Impact factor: 25.476
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.